# Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT

Study · id `cardio:ct-nct07554170` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07554170](<https://clinicaltrials.gov/study/NCT07554170>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07554170

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

## Technical summary

Registry record NCT07554170. Randomized; no masking; primary purpose treatment. Start 2024-05-21 (actual); primary completion 2025-12-21 (actual). Results posted on 2026-11-06.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 134 participants (enrolled count; ClinicalTrials.gov record NCT07554170, source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)
- Started: 2024-05-21 (actual) (ClinicalTrials.gov record NCT07554170, source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)
- Primary completion: 2025-12-21 (actual) (ClinicalTrials.gov record NCT07554170, source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)
- Completion: 2025-12-21 (actual) (ClinicalTrials.gov record NCT07554170, source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)
- Results first posted: 2026-11-06 (ClinicalTrials.gov record NCT07554170, source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)
- Countries: Iran (ClinicalTrials.gov record NCT07554170, source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07554170-2026-11-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT
- Condition: Supraventricular Tachycardia
- Condition: Supraventricular Tachycardias
- Condition: Supraventricular Arrhythmia
- Condition: SVT
- Condition: PSVT
- Intervention (Drug): Single-syringe Adenosine
- Intervention (Drug): Double Syringe Adenosine
- Lead sponsor: Hormozgan University of Medical Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`)

## Provenance

Content hash: cbdb3d7f3aadf858f2b2850bcc97a5a8dec6ef985beeeb0bc28dda918eb818dd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
